Skip to search formSkip to main contentSkip to account menu

cethromycin

Known as: (1S,2R,5R,7R,8R,9S,11R,13R,14R)-8-[(2S,3R,4S,6R)- 4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13- hexamethyl-9-[(E)-3-quinolin-3-ylprop-2-enoxy] -3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

A 195773

Broader (2)

Anti-Bacterial AgentsKetolides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Current treatment of community-acquired pneumonia
Introduction: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Management decisions… 
Review
2009
Review
2009
Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium.
Nosocomially acquired intracranial infections may be caused by a wide array of microorganisms, including staphylococci… 
Review
2008
Review
2008
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.
BACKGROUND The ketolides are a subclass of macrolides, which were designed specifically to overcome macrolide-resistant… 
2006
2006
Efficacy of Cethromycin, a New Ketolide, against Streptococcus pneumoniae Susceptible or Resistant to Erythromycin in a Murine Pneumonia Model
ABSTRACT Cethromycin is a ketolide with in vitro activity against macrolide-sensitive and -resistant strains of Streptococcus… 
2003
2003
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
The in vitro activities of telithromycin and cethromycin (ABT-773) against 412 Streptococcus pyogenes isolates, consecutively… 
2003
2003
Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Nasopharyngeal specimens for culture of Chlamydia pneumoniae were obtained from patients with community-acquired pneumonia… 
2003
2003
In Vitro Activities of Cethromycin (ABT-773), a New Ketolide, against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or Macrolides
ABSTRACT Pneumococcal resistance to antimicrobials presents problems to physicians for empirical treatment of acute otitis media… 
Review
2003
Review
2003
Recent developments in macrolide antimicrobial research.
Clarithromycin and azithromycin, which are more acid-stable than erythromycin A (EM), have been widely prescribed for the… 
2003
2003
Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes.
OBJECTIVES To evaluate the penetration of ketolide cethromycin (ABT-773) into human polymorphonuclear leucocytes (PMNs) and its… 
2002
2002
Bactericidal Effect and Pharmacodynamics of Cethromycin (ABT-773) in a Murine Pneumococcal Pneumonia Model
ABSTRACT Cethromycin (ABT-773), a new ketolide, possesses potent in vitro activity against Streptococcus pneumoniae. The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)